PMID- 30250170 OWN - NLM STAT- MEDLINE DCOM- 20190115 LR - 20240313 IS - 2041-1723 (Electronic) IS - 2041-1723 (Linking) VI - 9 IP - 1 DP - 2018 Sep 24 TI - Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo. PG - 3881 LID - 10.1038/s41467-018-06349-0 [doi] LID - 3881 AB - Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) strategies with proven in vivo efficacy rely on antiretroviral drugs, creating the potential for drug resistance and complicated treatment options in individuals who become infected. Moreover, on-demand products are currently missing from the PrEP development portfolio. Griffithsin (GRFT) is a non-antiretroviral HIV entry inhibitor derived from red algae with an excellent safety profile and potent activity in vitro. When combined with carrageenan (CG), GRFT has strong activity against herpes simplex virus-2 (HSV-2) and human papillomavirus (HPV) in vitro and in vivo. Here, we report that GRFT/CG in a freeze-dried fast dissolving insert (FDI) formulation for on-demand use protects rhesus macaques from a high dose vaginal SHIV SF162P3 challenge 4 h after FDI insertion. Furthermore, the GRFT/CG FDI also protects mice vaginally against HSV-2 and HPV pseudovirus. As a safe, potent, broad-spectrum, on-demand non-antiretroviral product, the GRFT/CG FDI warrants clinical development. FAU - Derby, Nina AU - Derby N AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. nderby@popcouncil.org. FAU - Lal, Manjari AU - Lal M AD - PATH, 2201 Westlake Ave, Suite 200, Seattle, WA, 98121, USA. FAU - Aravantinou, Meropi AU - Aravantinou M AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Kizima, Larisa AU - Kizima L AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Barnable, Patrick AU - Barnable P AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Rodriguez, Aixa AU - Rodriguez A AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Lai, Manshun AU - Lai M AD - PATH, 2201 Westlake Ave, Suite 200, Seattle, WA, 98121, USA. FAU - Wesenberg, Asa AU - Wesenberg A AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Ugaonkar, Shweta AU - Ugaonkar S AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Levendosky, Keith AU - Levendosky K AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Mizenina, Olga AU - Mizenina O AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Kleinbeck, Kyle AU - Kleinbeck K AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Lifson, Jeffrey D AU - Lifson JD AD - AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, 8560 Progress Dr, Frederick, MD, 21701, USA. FAU - Peet, M Melissa AU - Peet MM AD - MPI Research, 54943 N. Main St, Mattawan, MI, 49071, USA. FAU - Lloyd, Zachary AU - Lloyd Z AD - MPI Research, 54943 N. Main St, Mattawan, MI, 49071, USA. FAU - Benson, Michael AU - Benson M AD - MPI Research, 54943 N. Main St, Mattawan, MI, 49071, USA. FAU - Heneine, Walid AU - Heneine W AD - Centers for Disease Control, 1600 Clifton Rd, Atlanta, GA, 30333, USA. FAU - O'Keefe, Barry R AU - O'Keefe BR AUID- ORCID: 0000-0003-0772-4856 AD - Molecular Targets Program, Center for Cancer Research, and Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Building 560, Room 21-105, Frederick, MD, 21702-1201, USA. FAU - Robbiani, Melissa AU - Robbiani M AD - MJR4CONSULTING, New York, 10065, NY, USA. FAU - Martinelli, Elena AU - Martinelli E AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Grasperge, Brooke AU - Grasperge B AD - Tulane National Primate Research Center, 18703 Three Rivers Rd, Covington, LA, 70433-8915, USA. FAU - Blanchard, James AU - Blanchard J AD - Tulane National Primate Research Center, 18703 Three Rivers Rd, Covington, LA, 70433-8915, USA. FAU - Gettie, Agegnehu AU - Gettie A AD - Aaron Diamond AIDS Research Center, 455 1st Ave. #7, New York, NY, 10016, USA. FAU - Teleshova, Natalia AU - Teleshova N AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. FAU - Fernandez-Romero, Jose A AU - Fernandez-Romero JA AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. AD - Science Department, Borough of Manhattan Community College, 199 Chambers St, New York, NY, 10007, USA. FAU - Zydowsky, Thomas M AU - Zydowsky TM AD - Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY, 10065, USA. LA - eng GR - P51 OD011104/OD/NIH HHS/United States GR - HHSN261200800001E/CA/NCI NIH HHS/United States GR - HHSN261200800001C/RC/CCR NIH HHS/United States GR - HHSN261200800001E/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180924 PL - England TA - Nat Commun JT - Nature communications JID - 101528555 RN - 0 (Antiviral Agents) RN - 0 (Plant Lectins) RN - 9000-07-1 (Carrageenan) RN - Z8PX5UX50U (griffithsin protein, Griffithsia) SB - IM MH - Acquired Immunodeficiency Syndrome/*prevention & control MH - Administration, Intravaginal MH - Animals MH - Antiviral Agents/chemistry/*therapeutic use MH - Carrageenan/chemistry/*therapeutic use MH - Disease Models, Animal MH - Drug Compounding/methods MH - Drug Evaluation, Preclinical MH - Female MH - Freeze Drying MH - Herpes Genitalis/*prevention & control/virology MH - Herpesvirus 2, Human/pathogenicity MH - Humans MH - Macaca mulatta MH - Male MH - Papillomavirus Infections/*prevention & control/virology MH - Plant Lectins/chemistry/genetics/isolation & purification/*therapeutic use MH - Plants, Genetically Modified/genetics/metabolism MH - Pre-Exposure Prophylaxis/methods MH - Simian Acquired Immunodeficiency Syndrome/prevention & control MH - Simian Immunodeficiency Virus/pathogenicity MH - Nicotiana/genetics/metabolism MH - Treatment Outcome MH - Vagina/virology PMC - PMC6155161 COIS- The authors declare no competing interests. EDAT- 2018/09/27 06:00 MHDA- 2019/01/16 06:00 PMCR- 2018/09/24 CRDT- 2018/09/26 06:00 PHST- 2018/04/13 00:00 [received] PHST- 2018/08/24 00:00 [accepted] PHST- 2018/09/26 06:00 [entrez] PHST- 2018/09/27 06:00 [pubmed] PHST- 2019/01/16 06:00 [medline] PHST- 2018/09/24 00:00 [pmc-release] AID - 10.1038/s41467-018-06349-0 [pii] AID - 6349 [pii] AID - 10.1038/s41467-018-06349-0 [doi] PST - epublish SO - Nat Commun. 2018 Sep 24;9(1):3881. doi: 10.1038/s41467-018-06349-0.